Symbols
Aime
Products
News
Market
Portfolio
Brokers
US Stocks
/
SLN
/
revenue
S
SLN
EPS
Revenue & Expenses
How did Silence Therapeutics' revenue and expenses shift in Q4 2024?
Ask Aime more questions
